Search Orphan Drug Designations and Approvals
-
Generic Name: | ATI-450, an orally available small molecule inhibitor of the p38alpha mitogen activated protein kinase (MAPK)/MAPK-activated protein kinase 2 (MK2) inflammatory signaling pathway |
---|---|
Date Designated: | 01/21/2021 |
Orphan Designation: | Treatment of cryopyrin-associated periodic syndrome |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 01/03/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Aclaris Theapeutics Inc. 701 Lee Road, Suite 103 Wayne, Pennsylvania 19087 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-